Answers are grounded in this paper and cite their sources.
To evaluate the impact of Pulmonary Arterial Hypertension (PAH) therapies on the incidence of pericardial effusion and its prognostic implications for patient survival.
No takes yet. Share an insight, caveat, or question.
Albulushi et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: